iRegene Therapeutics raised an undisclosed amount in Series B+ funding led by Northern Light Venture Capital to accelerate clinical development for Parkinson’s disease and retinal degenerative diseases.
Round Type
Series B
WuhanBiotechnologyHealth CareTherapeuticsInvestors
Description
iRegene Therapeutics, a biotechnology company, raised an undisclosed amount in Series B+ funding. The round was led by Northern Light Venture Capital, Chuangjing Capital, and OneHealth Haihe Capital. The funds will be used for global clinical development of NouvNeu001 and NouvSight001, and to strengthen R&D and manufacturing capabilities.
Quick answer
iRegene Therapeutics raised an undisclosed amount in a Series B round, dated September 9, 2025. Investors: OneHealth Haihe Capital, Northern Light Venture Capital and Chuangjing Capital. iRegene Therapeutics is based in Wuhan, Hubei, China.
- How much did iRegene Therapeutics raise?
- iRegene Therapeutics raised an undisclosed amount in a Series B round on September 9, 2025.
- Who invested in iRegene Therapeutics?
- OneHealth Haihe Capital, Northern Light Venture Capital and Chuangjing Capital are named as investors in this round.
- What does iRegene Therapeutics do?
- iRegene Therapeutics is a biotechnology company specializing in chemically induced allogeneic cell therapy.
- Where is iRegene Therapeutics based and how big is it?
- iRegene Therapeutics is based in Wuhan, Hubei, China.
- Who are the decision-makers at iRegene Therapeutics?
- Fundz holds 1 contact at iRegene Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as iRegene Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Acasti raised $4M (Funding Round) on October 23, 2025.
- ENA Respiratory raised $22M (Series B) on October 22, 2025.
- Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
- Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
- Valink Therapeutics raised $12M (Pre-Series A) on October 20, 2025.
- Theriva Biologics raised $13M on October 17, 2025.
Who to call at iRegene Therapeutics, and when
A new round usually means iRegene Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day iRegene Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at iRegene Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at iRegene Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment iRegene Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansiRegene Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.